Geode Capital Management LLC Has $8.93 Million Stake in AngioDynamics, Inc. (NASDAQ:ANGO)

Geode Capital Management LLC grew its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO) by 1.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 974,302 shares of the medical instruments supplier’s stock after buying an additional 13,535 shares during the period. Geode Capital Management LLC’s holdings in AngioDynamics were worth $8,927,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of the stock. SBI Securities Co. Ltd. bought a new position in AngioDynamics during the 4th quarter worth approximately $28,000. R Squared Ltd bought a new position in shares of AngioDynamics during the fourth quarter worth $49,000. US Bancorp DE boosted its position in shares of AngioDynamics by 1,938.0% during the fourth quarter. US Bancorp DE now owns 6,705 shares of the medical instruments supplier’s stock worth $61,000 after purchasing an additional 6,376 shares in the last quarter. SG Americas Securities LLC grew its holdings in shares of AngioDynamics by 21.3% in the 4th quarter. SG Americas Securities LLC now owns 16,102 shares of the medical instruments supplier’s stock valued at $147,000 after buying an additional 2,832 shares during the period. Finally, Intech Investment Management LLC bought a new stake in shares of AngioDynamics in the 4th quarter valued at $152,000. 89.43% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reiterated a “buy” rating and set a $16.00 target price (up from $15.00) on shares of AngioDynamics in a report on Monday, April 7th.

AngioDynamics Stock Performance

NASDAQ ANGO opened at $9.36 on Thursday. The stock has a market cap of $379.88 million, a price-to-earnings ratio of -1.66 and a beta of 0.52. The business has a 50 day simple moving average of $9.60 and a 200 day simple moving average of $9.06. AngioDynamics, Inc. has a 52-week low of $5.47 and a 52-week high of $13.50.

AngioDynamics (NASDAQ:ANGO) last issued its quarterly earnings data on Wednesday, April 2nd. The medical instruments supplier reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.13) by $0.16. The company had revenue of $72.00 million during the quarter, compared to the consensus estimate of $70.30 million. AngioDynamics had a negative net margin of 79.38% and a negative return on equity of 7.26%. The company’s quarterly revenue was down 4.3% compared to the same quarter last year. On average, analysts predict that AngioDynamics, Inc. will post -0.37 EPS for the current year.

AngioDynamics Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.